{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:20:25Z","timestamp":1786990825766,"version":"build-2736575974"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["755170-2"],"award-info":[{"award-number":["755170-2"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["40-419000-98-020"],"award-info":[{"award-number":["40-419000-98-020"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21CC0073729"],"award-info":[{"award-number":["NNF21CC0073729"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.imlet.2024.106931","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T05:02:17Z","timestamp":1726635737000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs"],"prefix":"10.1016","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9249-3812","authenticated-orcid":false,"given":"Giorgio","family":"Gilioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7802","authenticated-orcid":false,"given":"Sander","family":"de Kivit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-8519","authenticated-orcid":false,"given":"Frank J.T.","family":"Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-2728","authenticated-orcid":false,"given":"Lisa M.","family":"Ott de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0003","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0004","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.2022017667","article-title":"Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT","volume":"141","author":"Schuetz","year":"2023","journal-title":"Blood"},{"issue":"5466","key":"10.1016\/j.imlet.2024.106931_bib0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"issue":"9452","key":"10.1016\/j.imlet.2024.106931_bib0006","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"issue":"5577","key":"10.1016\/j.imlet.2024.106931_bib0007","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0008","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15252\/emmm.201707573","article-title":"Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products","volume":"9","author":"Aiuti","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0010","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0092-8674(89)90760-5","article-title":"The V(D)J recombination activating gene, RAG-1","volume":"59","author":"Schatz","year":"1989","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.imlet.2024.106931_bib0011","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1093\/emboj\/cdf394","article-title":"Ordered assembly of the V(D)J synaptic complex ensures accurate recombination","volume":"21","author":"Jones","year":"2002","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0012","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.179.4.1355","article-title":"Two waves of recombinase gene expression in developing thymocytes","volume":"179","author":"Wilson","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2024.106931_bib0013","doi-asserted-by":"crossref","unstructured":"Cordes M., Cante-Barrett K., van den Akker E.B., et al. Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the human thymus. Sci. Immunol. 2022;7(77):eade0182. doi:10.1126\/sciimmunol.ade0182.","DOI":"10.1126\/sciimmunol.ade0182"},{"key":"10.1016\/j.imlet.2024.106931_bib0014","doi-asserted-by":"crossref","unstructured":"Gan T., Wang Y., Liu Y., Schatz D.G., Hu J. RAG2 abolishes RAG1 aggregation to facilitate V(D)J recombination. Cell Rep. 2021;37(2):109824. doi:10.1016\/j.celrep.2021.109824.","DOI":"10.1016\/j.celrep.2021.109824"},{"key":"10.1016\/j.imlet.2024.106931_bib0015","doi-asserted-by":"crossref","unstructured":"Grawunder U., Leu T.M., Schatz D.G., et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity. 1995;3(5):601\u20138. doi:10.1016\/1074-7613(95)90131-0.","DOI":"10.1016\/1074-7613(95)90131-0"},{"key":"10.1016\/j.imlet.2024.106931_bib0016","doi-asserted-by":"crossref","unstructured":"Zhang L., Reynolds T.L., Shan X., Desiderio S. Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity. 2011;34(2):163\u201374. doi:10.1016\/j.immuni.2011.02.003.","DOI":"10.1016\/j.immuni.2011.02.003"},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0017","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2005.05.011","article-title":"Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle","volume":"18","author":"Jiang","year":"2005","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0018","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1074-7613(00)80272-1","article-title":"A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle","volume":"5","author":"Li","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2024.106931_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.ai.2018.07.001","article-title":"RAG chromatin scanning during V(D)J recombination and chromatin loop extrusion are related processes","volume":"139","author":"Lin","year":"2018","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.imlet.2024.106931_bib0020","doi-asserted-by":"crossref","unstructured":"Schlissel M.S., Stanhope-Baker P. Accessibility and the developmental regulation of V(D)J recombination. Semin Immunol. 1997;9(3):161\u201370. doi:10.1006\/smim.1997.0066.","DOI":"10.1006\/smim.1997.0066"},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coi.2009.03.008","article-title":"Mechanisms controlling expression of the RAG locus during lymphocyte development","volume":"21","author":"Kuo","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2024.106931_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659761","article-title":"The Interplay Between Chromatin Architecture and Lineage-Specific Transcription Factors and the Regulation of Rag Gene Expression","volume":"12","author":"Miyazaki","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0023","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.4049\/jimmunol.159.9.4382","article-title":"Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions","volume":"159","author":"Zarrin","year":"1997","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0024","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/MCB.19.4.2601","article-title":"Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines","volume":"19","author":"Lauring","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2024.106931_bib0025","doi-asserted-by":"crossref","unstructured":"Hsu L.Y., Lauring J., Liang H.E., et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity. 2003;19(1):105\u201317. doi:10.1016\/s1074-7613(03)00181-x.","DOI":"10.1016\/S1074-7613(03)00181-X"},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0026","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ni1053","article-title":"A cis element in the recombination activating gene locus regulates gene expression by counteracting a distant silencer","volume":"5","author":"Yannoutsos","year":"2004","journal-title":"Nat. Immunol."},{"issue":"5021","key":"10.1016\/j.imlet.2024.106931_bib0027","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1126\/science.1831564","article-title":"Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking","volume":"253","author":"Turka","year":"1991","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0952-7915(97)80146-X","article-title":"Early alpha beta T cell development in the thymus of normal and genetically altered mice","volume":"9","author":"Fehling","year":"1997","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2024.106931_bib0029","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/ni1379","article-title":"Regulation of T cell receptor-alpha gene recombination by transcription","volume":"7","author":"Abarrategui","year":"2006","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(00)80286-1","article-title":"BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro","volume":"6","author":"Hertz","year":"1997","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.imlet.2024.106931_bib0031","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.94.17.9267","article-title":"Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest","volume":"94","author":"Melamed","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6480","key":"10.1016\/j.imlet.2024.106931_bib0032","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay3224","article-title":"A cell atlas of human thymic development defines T cell repertoire formation","volume":"367","author":"Park","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.imlet.2024.106931_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1210818","article-title":"The recombinase activating genes: architects of immune diversity during lymphocyte development","volume":"14","author":"Braams","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0034","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/eji.202048880","article-title":"RAG deficiencies: recent advances in disease pathogenesis and novel therapeutic approaches","volume":"51","author":"Bosticardo","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0035","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.181.3.1187","article-title":"Development of CD4+CD8+ thymocytes in RAG-deficient mice through a T cell receptor beta chain-independent pathway","volume":"181","author":"Guidos","year":"1995","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.08.022","article-title":"Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells","volume":"137","author":"Wiekmeijer","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0037","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2013.10.007","article-title":"A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency","volume":"133","author":"Lee","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0038","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0039","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2013.11.028","article-title":"Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes","volume":"133","author":"IJ","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.20151116","article-title":"Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects","volume":"213","author":"Rigoni","year":"2016","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0041","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10875-018-0537-4","article-title":"RAG deficiency: two genes, many diseases","volume":"38","author":"Delmonte","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0042","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0043","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2017.07.010","article-title":"The Mechanisms of T Cell Selection in the Thymus","volume":"38","author":"Takaba","year":"2017","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2009-03-211029","article-title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome","volume":"114","author":"Poliani","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/ACI.0b013e3283327e5c","article-title":"Thymus microenvironment in human primary immunodeficiency diseases","volume":"9","author":"Poliani","year":"2009","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0046","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jaci.2017.08.001","article-title":"Abnormalities of T-cell receptor repertoire in CD4(+) regulatory and conventional T cells in patients with RAG mutations: implications for autoimmunity","volume":"140","author":"Rowe","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0047","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1172\/JCI91162","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"126","author":"Walter","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0048","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI25221","article-title":"A variant of SCID with specific immune responses and predominance of gamma delta T cells","volume":"115","author":"Ehl","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0049","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI25178","article-title":"A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection","volume":"115","author":"de Villartay","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0050","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20091927","article-title":"Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency","volume":"207","author":"Walter","year":"2010","journal-title":"J. Exp. Med."},{"issue":"7583","key":"10.1016\/j.imlet.2024.106931_bib0051","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex-linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"issue":"7608","key":"10.1016\/j.imlet.2024.106931_bib0052","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(69)92112-6","article-title":"Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency","volume":"1","author":"De Koning","year":"1969","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0053","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/ACI.0000000000000952","article-title":"Advances in gene therapy for inborn errors of immunity","volume":"23","author":"Ott de Bruin","year":"2023","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0054","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","article-title":"Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity","volume":"107","author":"Lagresle-Peyrou","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0185","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1128\/JVI.73.3.1828-1834.1999","article-title":"Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors","volume":"73","author":"Gasmi","year":"1999","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0186","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0092-8674(00)80828-4","article-title":"HIV-1 genome nuclear import is mediated by a central DNA flap","volume":"101","author":"Zennou","year":"2000","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0076","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0056","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(83)90344-6","article-title":"Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus","volume":"33","author":"Mann","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2024.106931_bib0055","article-title":"A novel branched DNA-based flowcytometric method for single-cell characterization of gene therapy products and expression of therapeutic genes","volume":"11","author":"Garcia-Perez","year":"2020","journal-title":"Front. Immunol."},{"issue":"5934","key":"10.1016\/j.imlet.2024.106931_bib0057","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/305556a0","article-title":"Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells","volume":"305","author":"Joyner","year":"1983","journal-title":"Nature"},{"issue":"5977","key":"10.1016\/j.imlet.2024.106931_bib0058","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/310476a0","article-title":"Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse","volume":"310","author":"Williams","year":"1984","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0059","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1182\/blood.V82.7.1975.1975","article-title":"Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells","volume":"82","author":"Bodine","year":"1993","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.imlet.2024.106931_bib0061","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0062","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0063","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0064","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"227","key":"10.1016\/j.imlet.2024.106931_bib0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome\u2013long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0066","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/JVI.00011-14","article-title":"Enhancers are major targets for murine leukemia virus vector integration","volume":"88","author":"De Ravin","year":"2014","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0067","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1093\/nar\/gkt1399","article-title":"MLV integration site selection is driven by strong enhancers and active promoters","volume":"42","author":"LaFave","year":"2014","journal-title":"Nucleic. Acids. Res."},{"issue":"5626","key":"10.1016\/j.imlet.2024.106931_bib0068","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.1083413","article-title":"Transcription start regions in the human genome are favored targets for MLV integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science"},{"issue":"5259","key":"10.1016\/j.imlet.2024.106931_bib0069","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.imlet.2024.106931_bib0070","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2024.106931_bib0071","doi-asserted-by":"crossref","unstructured":"Lagresle-Peyrou C., Benjelloun F., Hue C., et al. Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients. Mol. Ther. 2008;16(2):396\u2013403. doi:10.1038\/sj.mt.6300353.","DOI":"10.1038\/sj.mt.6300353"},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0072","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.imlet.2024.106931_bib0073","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.omtm.2020.03.016","article-title":"Successful preclinical development of gene therapy for recombinase-activating gene-1-deficient SCID","author":"Garcia-Perez","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.imlet.2024.106931_bib0074","doi-asserted-by":"crossref","unstructured":"Sorel N., Diaz-Pascual F., Bessot B., et al. Restoration of T and B Cell differentiation after RAG1 gene transfer in human RAG1 defective hematopoietic stem cells. Biomedicines. 2024;12(7)doi:10.3390\/biomedicines12071495.","DOI":"10.3390\/biomedicines12071495"},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0075","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0958-1669(95)80082-4","article-title":"Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli","volume":"6","author":"Kane","year":"1995","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.imlet.2024.106931_bib0077","doi-asserted-by":"crossref","unstructured":"Schwarzer A., Talbot S.R., Selich A., et al. Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning. Mol Ther. 2021;29(12):3383\u20133397. doi:10.1016\/j.ymthe.2021.06.017.","DOI":"10.1016\/j.ymthe.2021.06.017"},{"issue":"7313","key":"10.1016\/j.imlet.2024.106931_bib0078","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2024.106931_bib0079","doi-asserted-by":"crossref","unstructured":"Fraietta J.A., Nobles C.L., Sammons M.A., et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature. 2018;558(7709):307\u2013312. doi:10.1038\/s41586-018-0178-z.","DOI":"10.1038\/s41586-018-0178-z"},{"key":"10.1016\/j.imlet.2024.106931_bib0080","doi-asserted-by":"crossref","unstructured":"Shah N.N., Qin H., Yates B., et al. Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy. Blood Adv. 2019;3(15):2317\u20132322. doi:10.1182\/bloodadvances.2019000219.","DOI":"10.1182\/bloodadvances.2019000219"},{"issue":"17","key":"10.1016\/j.imlet.2024.106931_bib0081","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5954","key":"10.1016\/j.imlet.2024.106931_bib0082","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.imlet.2024.106931_bib0083","series-title":"Proceedings of the 25th ASGCT meeting, Molecular Therapy","article-title":"Myelodysplastic syndromes after eli-cel gene therapy for cerebral adrenoleukodystrophy (CALD)","year":"2022"},{"issue":"15","key":"10.1016\/j.imlet.2024.106931_bib0084","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2020010260","article-title":"Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency","volume":"138","author":"Reinhardt","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2024.106931_bib0090","doi-asserted-by":"crossref","unstructured":"Wayne J., Suh H., Misulovin Z., Sokol K.A., Inaba K., Nussenzweig M.C. A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development. Immunity. 1994;1(2):95\u2013107. doi:10.1016\/1074-7613(94)90103-1.","DOI":"10.1016\/1074-7613(94)90103-1"},{"key":"10.1016\/j.imlet.2024.106931_bib0085","doi-asserted-by":"crossref","unstructured":"Multhaup M., Karlen A.D., Swanson D.L., et al. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Hum Gene Ther. 2010;21(7):865\u201375. doi:10.1089\/hum.2009.162.","DOI":"10.1089\/hum.2009.162"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0086","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/hum.2016.064","article-title":"Lentivirus mediated correction of artemis-deficient severe combined immunodeficiency","volume":"28","author":"Punwani","year":"2017","journal-title":"Hum. Gene Ther."},{"issue":"25","key":"10.1016\/j.imlet.2024.106931_bib0087","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa2206575","article-title":"Lentiviral gene therapy for artemis-deficient SCID","volume":"387","author":"Cowan","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0088","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0089","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41591-021-01641-x","article-title":"Long-term safety and efficacy of lentiviral hematopoietic stem\/progenitor cell gene therapy for Wiskott-Aldrich syndrome","volume":"28","author":"Magnani","year":"2022","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.imlet.2024.106931_bib0091","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1084\/jem.20101136","article-title":"Promoters, enhancers, and transcription target RAG1 binding during V(D)J recombination","volume":"207","author":"Ji","year":"2010","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0092","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"39","key":"10.1016\/j.imlet.2024.106931_bib0093","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6096","key":"10.1016\/j.imlet.2024.106931_bib0094","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.imlet.2024.106931_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA double-strand breaks by the nonhomologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imlet.2024.106931_bib0096","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0097","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.imlet.2024.106931_bib0098","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.imlet.2024.106931_bib0099","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1093\/emboj\/17.18.5497","article-title":"Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells","volume":"17","author":"Takata","year":"1998","journal-title":"EMBO J."},{"issue":"7629","key":"10.1016\/j.imlet.2024.106931_bib0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0101","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-Specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2024.106931_bib0102","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"issue":"411","key":"10.1016\/j.imlet.2024.106931_bib0103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.imlet.2024.106931_bib0104","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt.3408","article-title":"Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.2022019333","article-title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","volume":"142","author":"Vavassori","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.imlet.2024.106931_bib0106","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","article-title":"Global transcriptional response to CRISPR\/Cas9-AAV6-based genome editing in CD34(+) hematopoietic stem and progenitor cells","volume":"26","author":"Cromer","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imlet.2024.106931_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2020.107550","article-title":"Correlation between the loss of intracellular molecules and cell viability after cell electroporation","volume":"135","author":"Jakstys","year":"2020","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.imlet.2024.106931_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation - A review","volume":"141","author":"Batista Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0109","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu. Rev. Virol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0110","doi-asserted-by":"crossref","first-page":"e58757","DOI":"10.1371\/journal.pone.0058757","article-title":"High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"issue":"733","key":"10.1016\/j.imlet.2024.106931_bib0111","doi-asserted-by":"crossref","first-page":"eadh8162","DOI":"10.1126\/scitranslmed.adh8162","article-title":"Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency","volume":"16","author":"Castiello","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.imlet.2024.106931_bib0112","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148887","article-title":"RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production","volume":"6","author":"Min","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","article-title":"Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids","volume":"14","author":"Seet","year":"2017","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0114","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic Rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2024.106931_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2017.07.147","article-title":"First case of autonomic dysreflexia following elective lower thoracic spinal cord transection in a spina bifida adult","volume":"108","author":"Garces","year":"2017","journal-title":"World Neurosurg."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0116","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","article-title":"A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency","volume":"134","author":"Abolhassani","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0117","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1542\/peds.2009-3171","article-title":"Highly variable clinical phenotypes of hypomorphic RAG1 mutations","volume":"126","author":"Avila","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humimm.2012.10.010","article-title":"Late-onset combined immune deficiency associated to skin granuloma due to heterozygous compound mutations in RAG1 gene in a 14 years old male","volume":"74","author":"Sharapova","year":"2013","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0119","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s10875-014-0077-5","article-title":"Atypical severe combined immunodeficiency caused by a novel homozygous mutation in Rag1 gene in a girl who presented with pyoderma gangrenosum: a case report and literature review","volume":"34","author":"Patiroglu","year":"2014","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2018.04.027","article-title":"Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype","volume":"143","author":"Tirosh","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0121","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s10875-015-0207-8","article-title":"Late onset hypomorphic RAG2 deficiency presentation with fatal vaccine-strain VZV infection","volume":"35","author":"Dutmer","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0122","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cei\/uxad110","article-title":"Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre","volume":"215","author":"Karaatmaca","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"13","key":"10.1016\/j.imlet.2024.106931_bib0123","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-07-165167","article-title":"Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation","volume":"113","author":"Giblin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2024.106931_bib0124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","article-title":"Mechanism of eukaryotic homologous recombination","volume":"77","author":"San Filippo","year":"2008","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0125","doi-asserted-by":"crossref","first-page":"e13545","DOI":"10.15252\/emmm.202013545","article-title":"Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome","volume":"13","author":"Vavassori","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0126","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108093","article-title":"Controlled cycling and quiescence enables efficient HDR in engraftment-enriched adult hematopoietic stem and progenitor cells","volume":"32","author":"Shin","year":"2020","journal-title":"Cell Rep."},{"issue":"360","key":"10.1016\/j.imlet.2024.106931_bib0128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9336","article-title":"Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells","volume":"8","author":"DeWitt","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0129","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","article-title":"Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates","volume":"27","author":"Romero","year":"2019","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymthe.2018.10.008","article-title":"Optimization of CRISPR\/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements","volume":"27","author":"Lattanzi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.imlet.2024.106931_bib0132","doi-asserted-by":"crossref","unstructured":"Lee B.C., Lozano R.J., Dunbar C.E. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells. Mol. Ther. 2021;29(11):3205\u20133218. doi:10.1016\/j.ymthe.2021.09.001.","DOI":"10.1016\/j.ymthe.2021.09.001"},{"key":"10.1016\/j.imlet.2024.106931_bib0133","doi-asserted-by":"crossref","unstructured":"Adikusuma F., Piltz S., Corbett M.A., et al. Large deletions induced by Cas9 cleavage. Nature. 2018;560(7717):E8\u2013E9. doi:10.1038\/s41586-018-0380-z.","DOI":"10.1038\/s41586-018-0380-z"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0134","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1038\/s41467-021-25190-6","article-title":"CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells","volume":"12","author":"Boutin","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0136","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell."},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107689","article-title":"Detection of deleterious on-target effects after HDR-mediated CRISPR editing","volume":"31","author":"Weisheit","year":"2020","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007994","article-title":"Collateral damage and CRISPR genome editing","volume":"15","author":"Thomas","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.imlet.2024.106931_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0141","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target effects in CRISPR\/Cas9-mediated genome engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0142","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41467-017-00124-3","article-title":"Inactivation of Pol theta and C-NHEJ eliminates off-target integration of exogenous DNA","volume":"8","author":"Zelensky","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0143","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"18","key":"10.1016\/j.imlet.2024.106931_bib0144","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMc2313119","article-title":"Specificity of CRISPR-Cas9 editing in exagamglogene autotemcel","volume":"390","author":"Yen","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"50","key":"10.1016\/j.imlet.2024.106931_bib0145","doi-asserted-by":"crossref","first-page":"E10745","DOI":"10.1073\/pnas.1711979114","article-title":"Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks","volume":"114","author":"Paix","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169350","article-title":"Insertional mutagenesis by CRISPR\/Cas9 ribonucleoprotein gene editing in cells targeted for point mutation repair directed by short single-stranded DNA oligonucleotides","volume":"12","author":"Rivera-Torres","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2024.106931_bib0147","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s42003-019-0705-y","article-title":"Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair","volume":"2","author":"Sansbury","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.imlet.2024.106931_bib0148","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.omtn.2020.03.012","article-title":"gRNA sequence heterology tolerance catalyzed by CRISPR\/Cas in an in vitro homology-directed repair reaction","volume":"20","author":"Hewes","year":"2020","journal-title":"Mol Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.imlet.2024.106931_bib0149","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1101\/gad.280545.116","article-title":"Noncanonical views of homology-directed DNA repair","volume":"30","author":"Verma","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.imlet.2024.106931_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.730696","article-title":"DNA double-strand break repair: all roads lead to HeterochROMAtin marks","volume":"12","author":"Caron","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.imlet.2024.106931_bib0151","doi-asserted-by":"crossref","first-page":"33222","DOI":"10.1038\/srep33222","article-title":"DNA damage and repair modify DNA methylation and chromatin domain of the targeted locus: mechanism of allele methylation polymorphism","volume":"6","author":"Russo","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0152","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1371\/journal.pgen.0030110","article-title":"DNA damage, homology-directed repair, and DNA methylation","volume":"3","author":"Cuozzo","year":"2007","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0153","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","article-title":"Cas9 activates the p53 pathway and selects for p53-inactivating mutations","volume":"52","author":"Enache","year":"2020","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0154","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.stem.2024.04.005","article-title":"Impact of CRISPR\/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques","volume":"31","author":"Lee","year":"2024","journal-title":"Cell Stem Cell."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.seminhematol.2013.03.025","article-title":"Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models","volume":"50","author":"Larochelle","year":"2013","journal-title":"Semin. Hematol."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0156","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ymthe.2021.09.026","article-title":"Genome editing in large animal models","volume":"29","author":"Maynard","year":"2021","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0157","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2007-02-075382","article-title":"Hematopoietic stem-cell behavior in nonhuman primates","volume":"110","author":"Shepherd","year":"2007","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.imlet.2024.106931_bib0158","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/hum.2023.29234.bfs","article-title":"Graphite bio pauses lead gene editing program in sickle cell disease","volume":"34","author":"Philippidis","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.imlet.2024.106931_bib0159","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1268620","article-title":"Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations","volume":"14","author":"Castiello","year":"2023","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.imlet.2024.106931_bib0160","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1182\/bloodadvances.2022009051","article-title":"Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study","volume":"7","author":"Achini-Gutzwiller","year":"2023","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0161","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.imlet.2024.106931_bib0162","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0163","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/nar\/gkx1199","article-title":"Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs","volume":"46","author":"Ryan","year":"2018","journal-title":"Nucleic. Acids. Res."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0164","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41592-020-0771-6","article-title":"Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies","volume":"17","author":"Marino","year":"2020","journal-title":"Nat. Methods"},{"issue":"7900","key":"10.1016\/j.imlet.2024.106931_bib0166","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04470-1","article-title":"Structural basis for mismatch surveillance by CRISPR-Cas9","volume":"603","author":"Bravo","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.imlet.2024.106931_bib0167","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0168","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/crispr.2020.0092","article-title":"Catalytically enhanced Cas9 through directed protein evolution","volume":"4","author":"Hand","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.imlet.2024.106931_bib0169","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-biochem-013118-111730","article-title":"Evaluating and enhancing target specificity of gene-editing nucleases and deaminases","volume":"88","author":"Kim","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"10.1016\/j.imlet.2024.106931_bib0170","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2024.106931_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2024.03.006","article-title":"On- and off-target effects of paired CRISPR-Cas nickase in primary human cells","author":"Klermund","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0172","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/s41467-022-32233-z","article-title":"Ultra-deep sequencing validates safety of CRISPR\/Cas9 genome editing in human hematopoietic stem and progenitor cells","volume":"13","author":"Cromer","year":"2022","journal-title":"Nat. Commun."},{"issue":"6437","key":"10.1016\/j.imlet.2024.106931_bib0173","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.aav9023","article-title":"Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq","volume":"364","author":"Wienert","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.imlet.2024.106931_bib0174","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nprot.2016.043","article-title":"Detecting DNA double-stranded breaks in mammalian genomes by linear amplification-mediated high-throughput genome-wide translocation sequencing","volume":"11","author":"Hu","year":"2016","journal-title":"Nat. Protoc."},{"issue":"17","key":"10.1016\/j.imlet.2024.106931_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2024.106931_bib0176","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/crispr.2020.0111","article-title":"Rescue of STAT3 function in hyper-IgE syndrome using adenine base editing","volume":"4","author":"Eberherr","year":"2021","journal-title":"CRISPR J."},{"issue":"7","key":"10.1016\/j.imlet.2024.106931_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.02.027","article-title":"Human T cell generation is restored in CD3delta severe combined immunodeficiency through adenine base editing","volume":"186","author":"McAuley","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0178","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/mt.2016.38","article-title":"Gene insertion into genomic safe harbors for human gene therapy","volume":"24","author":"Papapetrou","year":"2016","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2024.106931_bib0179","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2024.106931_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.682171","article-title":"Targeted gene delivery: where to land","volume":"3","author":"Pavani","year":"2021","journal-title":"Front. Genome Ed."},{"issue":"11","key":"10.1016\/j.imlet.2024.106931_bib0181","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.15252\/emmm.201707540","article-title":"Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients","volume":"9","author":"Diez","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.imlet.2024.106931_bib0182","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nbt.3513","article-title":"Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease","volume":"34","author":"De Ravin","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.imlet.2024.106931_bib0183","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell."},{"issue":"9","key":"10.1016\/j.imlet.2024.106931_bib0184","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.15252\/emmm.201707922","article-title":"Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells","volume":"9","author":"Piras","year":"2017","journal-title":"EMBO Mol. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:35:11Z","timestamp":1778632511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":186,"alternative-id":["S0165247824001056"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106931","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}